⏳ Fetching live dividend data...
Home › Calculator › RLFTD Dividend Calculator 2026
Relief Therapeutics Holding AG · OTC
Price: $4.08 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in RLFTD → $540.1K in 10 years · $14,804.01/month
Relief Therapeutics Holding AG operates as a biopharmaceutical firm, dedicated to providing vital therapeutic relief to patients suffering from severe diseases for which current medical solutions are insufficient. The company's reach extends across Switzerland, the broader European continent, North America, and various international markets. Its strategic focus is on advancing clinical-stage programs that leverage molecules with a proven history of clinical application. These programs are supported by either initial evidence of human biological activity or efficacy, or a strong scientific rationale. A key asset in their development pipeline is RLF-100, also known as aviptadil. This synthetic human vasoactive intestinal peptide (VIP) acts through diverse mechanisms, making it effective for a range of respiratory conditions. RLF-100 is currently undergoing Phase 3 clinical trials for treating acute respiratory distress syndrome and moderate-to-severe lung injury caused by COVID-19. Furthermore, it is in Phase 1 trials for managing acute lung injury in other intensive care unit settings, and in Phase 2 trials for addressing pulmonary sarcoidosis. Beyond RLF-100, Relief Therapeutics is also progressing with ACER-001, a distinct powder formulation of sodium phenylbutyrate. This compound has successfully completed Phase 3 trials for urea cycle disorders and is presently in Phase 1 for maple syrup urine disease. Additionally, the company is developing APR-TD011, a sprayable hypotonic acid-oxidizing solution, which is in Phase 2 development for the treatment of epidermolysis bullosa. Established in 2013, the company's main operations are based in Geneva, Switzerland.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RLFTD position with:
Real after-tax yield depends on where you live and how you hold RLFTD.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 49.02% | 46.22% | $4,902 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 41.67% | 38.87% | $4,167 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 39.22% | 36.42% | $3,922 / yr |
| 🇬🇧 UK ISA | 0% | 49.02% | 46.22% | $4,902 / yr |
| 🇬🇧 UK Taxable | 8.75% | 44.73% | 41.93% | $4,473 / yr |
| 🇨🇦 TFSA | 0% | 49.02% | 46.22% | $4,902 / yr |
| 🇨🇦 CA Taxable | 25% | 36.77% | 33.97% | $3,677 / yr |
| 🇦🇺 Super (pension) | 15% | 41.67% | 38.87% | $4,167 / yr |
| 🇦🇺 AU Taxable | 30% | 34.31% | 31.51% | $3,431 / yr |
| 🇩🇪 DE Taxable | 26.375% | 36.09% | 33.29% | $3,609 / yr |
| 🇫🇷 FR Taxable | 30% | 34.31% | 31.51% | $3,431 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
RLFTD pays quarterly — 4 times per year. Next ex-div: TBD.
How RLFTD compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RLFTD sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RLFTD dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Relief Therapeutics Holding AG (RLFTD) is currently trading at $4.08, 72% below its 52-week high. The current dividend yield is 49.02% based on an annual payout of $2.00 per share.
Relief Therapeutics Holding AG (RLFTD) is a healthcare stock currently trading at $4.08 with a dividend yield of 49.02%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →